Abstract 2532: integrated therapeutic antibody development at the National Research Council of Canada

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1158/1538-7445.AM2012-2532
AuthorSearch for: 1; Search for: 1
Name affiliation
  1. National Research Council of Canada. Human Health Therapeutics
FormatText, Article
Publication date
PublisherAmerican Association for Cancer Research
Peer reviewedYes
NPARC number23001785
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifier43e3adb3-7a37-4997-8810-9a01dd13295c
Record created2017-04-06
Record modified2020-04-21
Date modified: